About
About Journal
Editorial Board
Editorial Council
Journal Archive
Subscription
To Authors
Submissions
Publication Rules
Copyright
Privacy
Peer Review
Copyright Agreement
Send Article
Ethical Standards
Ethical principles
Authorship of publications
Borrowing and plagiarism
Generative artificial intelligence policy
Procedure for considering deviations from established ethical standards
Retraction of articles
Data sharing statement
Publication fee
Contacts
ru
en
ISSN 2075-3594 (Print)
ISSN 2414-9322 (Online)
About
About Journal
Editorial Board
Editorial Council
Journal Archive
Subscription
To Authors
Submissions
Publication Rules
Copyright
Privacy
Peer Review
Copyright Agreement
Send Article
Ethical Standards
Ethical principles
Authorship of publications
Borrowing and plagiarism
Generative artificial intelligence policy
Procedure for considering deviations from established ethical standards
Retraction of articles
Data sharing statement
Publication fee
Contacts
Logout
2009
№3
Loop diuretic treatment: time for new options
Keywords
loop diuretics
natriuresis
aldosterone
chronic heart failure
chronic kidney disease
Full text (in Russian)
Similar Articles
№1 / 2025
Levchenkova O.S., Novikov V.E., Vorobyeva V.V., Kozlov S.N.
Hif-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease
№1 / 2025
Mikhailova L.V., Perepelitsa S.A., Struchkov S.T., Orlova Yu.A., Akchurina K.N.
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development
№1 / 2026
Zhmurov V.A., Ermakova P.A., Ermakova A.A., Zhmurov D.V., Tolstouhova N.V.
Using predictive models to improve the quality of medical care for patients with chronic kidney disease in primary care settings
№4 / 2024
Yumasheva V.A., Komarova I.S., Rachina S.A., Mayorov V.V., Melnik D.M., Mirzakhamidova S.S.
Multifactorial kidney damage in a comorbid patient
№2 / 2025
Mikhailova Z.D., Saidov A.D., Cherepanova V.V.
Difficulties in diagnosing kidney damage in chronic lymphocytic leukemia and indolent lymphomas